Pushpom James*, Steven Daoud, Seleshi Demissie, Raisa Saab and Philip Roth

Department of Pediatrics, Staten Island University Hospital Northwell Health, Staten Island, New York, USA

*Corresponding Author: Pushpom James, Department of Pediatrics, Staten Island University Hospital Northwell Health, Staten Island, New York, USA.

Received: June 15, 2022; Published: July 27, 2022

Abstract

Introduction: Introduction: Obstructive sleep apnea hypopnea syndrome (OSAHS) is an independent risk factor for asthma exacerbations [1]. Since there is an overlap in symptoms between OSAHS and bronchial asthma, with good control of a patient’s asthma and allergic/non-allergic rhinitis, there should be fewer patients warranting work-up and treatment of obstructive sleep apnea.

Methodology: The goal was to determine the change on the sleep related breathing disorder scale (SRBD) once a patient’s asthma and allergic/non-allergic rhinitis had been controlled [2]. Two questionnaires were administered on patient’s first visit, the SRBD scale and depending on age, the Asthma Control Test (ACT) or Childhood ACT. These questionnaires were readministered on a subsequent visit once their asthma and allergic rhinitis were controlled [3].

Results: A total of 68 patients were recruited. 40 completed 2 visits according to protocol. Of these, 28, that is 70% of patients showed improvement on the SRBD scale once their asthma and allergic/non-allergic rhinitis were controlled.

Conclusion: By controlling a patient’s asthma and allergic/non-allergic rhinitis, we can increase the specificity of the SRBD scale in asthmatics. This may improve screening for pediatric obstructive sleep apnea in children with asthma with more appropriate usage of diagnostic tools such as polysomnography and perhaps decrease the use of unnecessary treatments and surgeries, such as, tonsillectomy and adenoidectomy.

Keywords: Asthma; Pediatric Pulmonology; Obstructive Sleep Apnea Hypopnea Syndrome; Pediatric Sleep Questionnaire; Asthma Control Test; Otolaryngology

References

1. Alkhalil M., et al. “Obstructive Sleep Apnea Syndrome and Asthma: What Are the Links?” Journal of Clinical Sleep Medicine1 (2009): 71-78.
2. Chervin RD., et al. “Pediatric sleep questionnaire (PSQ): validity and reliability of scales for sleep-disordered breathing, snoring, sleepiness, and behavioral problems”. Sleep Medicine1 (2000): 21-32.
3. Nathan RA., et al. “Development of the asthma control test: A survey for assessing asthma control”. Journal of Allergy and Clinical Imunology1 (2004): 59-65.
4. Zheng H., et al. “Leptin Promotes Allergic Airway Inflammation through Targeting the Unfolded Protein Response Pathway”. Scientific Reports 8 (2018): 8905.
5. Sanchez T., et al. “Sleep-disordered breathing in children with asthma: a systematic review on the impact of treatment”. Journal of Asthma and Allergy 9 (2016): 83-91.
6. Ehsan ZM., et al. “Validation of the pediatric sleep questionnaire in children with asthma”. Pediatric Pulmonology3 (2017): 382-389.
7. Davila DG. “National Sleep Foundation (2009).
8. American Academy of Sleep Medicine. “The AASM Manual for the Scoring of Sleep and Associated Events”. Summary of Updates in Version 2.5. American Academy of Sleep Medicine (2018).
9. Rosen CL., et al. “Prevalence and risk factors for sleep-disordered breathing in 8- to 11-year-old children: association with race and prematurity”. The Journal of Pediatrics4 (2003): 383-389.
10. Anuntaseree W., et al. “Snoring and obstructive sleep apnea in Thai school‐age children: Prevalence and predisposing factors. Pediatric Pulmonology 32.3 (2001): 222-227.
11. Ross KR., et al. “Sleep-Disordered Breathing is Associated with Asthma Severity in Children”. The Journal of Pediatrics5 (2012): 736-742.
12. Teodorescu M., et al. “Obstructive Sleep Apnea Risk, Asthma Burden, and Lower Airway Inflammation in Adults in the Severe Asthma Research Program (SARP) II”. Journal of Allergy and Clinical Immunology 4 (2015): 566-575.
13. National Sleep Foundation (2019).
14. Ginsberg D. “An Unidentified Monster in the Bed- Assessing Nocturnal Asthma in Children”. 12.1 (2009): 31-38.
15. National Jewish Health. National Jewish Health (2019).
16. Chervin RD., et al. “Prognosis for Spontaneous Resolution of OSA in Children”. CHEST Journal5 (2015): 1204-1213.
17. Liming BJ., et al. “Montelukast and Nasal Corticosteroids to Treat Pediatric Obstructive Sleep Apnea: A Systematic Review and Meta-analysis”. Otolaryngology Head and Neck Surgery4 (2018): 594-602.
18.  

Citation

Citation: Pushpom James., et al. “Does the Treatment of Asthma and Allergic Rhinitis Decrease the Likelihood of an Obstructive Sleep Apnea Work-up and Treatment?". Acta Scientific Paediatrics 5.8 (2022): 15-22.

Copyright

Copyright: © 2022 Pushpom James., et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.